Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SYF | Dividend Equivalent Unit | Award | $14.3K | +312 | +0.49% | $45.89 | 64.6K | Aug 15, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SYF | Phantom Stock Units | Award | $0 | +0.977 | +0.55% | $0.00 | 180 | Aug 15, 2024 | Common Stock | 0.977 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Represents dividend equivalent units accrued on August 15, 2024 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. |
F2 | The reported phantom stock units were acquired pursuant to a dividend reinvestment feature under the Synchrony Financial Deferred Compensation Plan (the "Deferred Compensation Plan") and are to be settled, in cash, six months following the Reporting Person's separation from service to the Company, subject to the requirements set forth in the Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of Synchrony Financial common stock. |
F3 | Includes 20.504 phantom stock units acquired from regular quarterly dividend reinvestments in the Deferred Compensation Plan from February 13, 2020 through May 15, 2024 that were inadvertently not reported previously due to an administrative error and not any error of the Reporting Person. |
EVP, CEO--Health & Wellness